ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - IMVT, HSACU, HSAC, HSACW

Author's Avatar
Feb 27, 2021
Article's Main Image

PR Newswire